Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

US STOCKS-S&P, Dow futures retreat as coronavirus cases spike

Published 17/11/2020, 15:08
© Reuters.

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* Tesla set to add $40 bln to market cap
* Walmart rises as profit beats on online boost
* Walgreen, CVS hammered by Amazon's online pharmacy foray
* Futures: Dow down 0.7%, S&P down 0.6%, Nasdaq up 0.3%

(Adds comments, details; Updates prices)
By Shivani Kumaresan and Medha Singh
Nov 17 (Reuters) - The S&P 500 and the Dow were set to open
lower on Tuesday, retreating from record closing highs a day
earlier as more U.S. states took measures to contain the
COVID-19 pandemic.
The Nasdaq 100 futures NQcv1 rose 0.3% as Tesla Inc's
TSLA.O shares soared 12.6% premarket in anticipation of a $51
billion trade by index funds adjusting their holdings when the
company is added to the benchmark S&P 500 in December.
The Dow notched an all-time closing high on Monday,
finishing about 50 points shy of 30,000 points after Moderna
Inc's MRNA.O promising COVID-19 vaccine data boosted hopes of
an economic recovery, overshadowing spiking coronavirus cases
across the country.
"There is conflict for the market between the near-term
direction to the economy, which is troubled with the very high
COVID-19 rates and the future for the market, that's which
vaccines could provide an end to the restrictions," said Rick
Meckler, partner at Cherry Lane Investments in New Vernon, New
Jersey.
New Jersey, California and Iowa imposed fresh restrictions
as the pandemic reached its most perilous point yet in the
United States, threatening to worsen as the colder weather sets
in.
At 08:22 a.m. ET, Dow E-minis 1YMcv1 were down 0.66% and
S&P 500 E-minis EScv1 were down 0.58%.
The second positive update from a U.S. vaccine trial has
encouraged investors to diversify into value stocks, which
outperformed growth stocks over the past week as they poised to
benefit from a pickup in the economy.
Amazon.com Inc AMZN.O rose 2.1% after it launched an
online pharmacy for delivering prescription medications in the
United States. Drug retailers such as Walgreens Boots Alliance
Inc WBA.O tumbled 9.1%, while CVS Health Corp CVS.N fell
7.3% on the news. Warren Buffett's Berkshire Hathaway Inc BRKa.N disclosed
new stakes worth $5.7 billion in drugmakers Abbvie Inc ABBV.N ,
Bristol-Myers Squibb Co BMY.N , Merck & Co MRK.N and Pfizer
Inc PFE.N , lifting their shares between 1.1% and 2.7%.
U.S. October retail sales missed estimates, increasing less
than expected, with retail earnings in focus this week as the
third-quarter earnings season enters its tail end. Walmart Inc WMT.N rose about 1% after posting a
bigger-than-expected increase in quarterly same-store sales.
Kohl's Corp KSS.N was down 1.5% after the department store
reported a bigger-than-expected decline in quarterly same-store
sales as the virus outbreak hammered demand for its apparel and
footwear.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.